News
Minimal TV viewing may be protective for heart diseases linked to Type 2 diabetes

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying levels of genetic risk for Type 2 diabetes, including high genetic risk, according to new research.
Atherosclerotic cardiovascular disease, or ASCVD, is caused by plaque buildup in arterial walls and refers to conditions that include heart disease, stroke and peripheral artery disease.
These conditions may lead to severe consequences, such as compromised quality of life, bypass surgeries, stenting procedures, amputations and premature death.
This study is one of the first to examine how the genetic risk for Type 2 diabetes may interact with TV viewing in relation to the future risk of atherosclerotic cardiovascular disease.
Youngwon Kim, Ph.D. is lead author of the study and a professor in the School of Public Health at The University of Hong Kong in Pokfulam, Hong Kong.
The researcher saod: “Type 2 diabetes and a sedentary lifestyle, including prolonged sitting, are major risk factors for atherosclerotic cardiovascular diseases.
“Watching TV, which accounts for more than half of daily sedentary behavior, is consistently associated with an increased risk of Type 2 diabetes and atherosclerosis.
Our study provides new insights into the roles of limiting TV viewing time in the prevention of atherosclerotic cardiovascular diseases for everyone and especially in people with a high genetic predisposition for Type 2 diabetes.”
This study examined data from a large biomedical database and research resource containing genetic, lifestyle and medical records for 346,916 UK adults, average age of 56 years, and 45 percentmale.
During nearly 14 years of follow-up, the study identified 21,265 people who developed atherosclerotic cardiovascular disease.
For each participant, researchers calculated a polygenic risk score for Type 2 diabetes based on 138 genetic variants associated with the condition.
A polygenic risk score is a statistical method to predict a person’s risk of developing a particular disease or condition by combining information from many genetic variants.
To categorise participants into genotype TV-viewing groups, researchers combined three categories of Type 2 diabetes genetic risk: low, medium and high, with two categories of participants who self-reported through questionnaires: watching TV either one hour or less a day, or two hours or more each day.
The analysis found:
- About 21 per cent of participants reported watching TV one hour or less a day; more than 79 per cent reported two or more hours per day of TV-watching time.
- Compared to watching TV for one hour or less daily, spending two hours or more daily in front of the TV was associated with a 12 per cent higher risk of atherosclerotic cardiovascular disease, regardless of their genetic risk for Type 2 diabetes.
- Evaluations indicated that participants with medium and high Type 2 diabetes genetic risk did not have a higher risk of developing atherosclerotic cardiovascular disease as long as TV viewing was limited to one hour or less daily.
- The 10-year absolute risk, or probability, of developing atherosclerotic cardiovascular disease was lower (2.13 per cent) for people with high Type 2 diabetes genetic risk combined with one hour or less daily of TV viewing compared to people with low Type 2 diabetes genetic risk and who reported two or more hours of daily TV viewing (2.46 per cent).
Mengyao Wang, Ph.D., and a recent Ph.D. graduate of The University of Hong Kong.
Wang said: “We found that people with high genetic risk for Type 2 diabetes may exhibit lower chances of developing atherosclerotic cardiovascular disease by limiting TV watching to one hour or less each day.
“This suggests that less TV viewing could serve as a key behavioral target for preventing atherosclerotic cardiovascular diseases linked to Type 2 diabetes genetics.
“Future strategies and actions to prevent disease and improve health by reducing time in front of the TV and promoting other healthy lifestyle modifications should target broad populations, including those with a high genetic risk for Type 2 diabetes.”
News
Gut-friendly foods may damage heart, charity warns
Wellness
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.













